The Increasing Investment in Research is Propelling the Growth of the Prostaglandin Market in the APAC Region!

The Asia Pacific prostaglandin market is a significant contributor to the global prostaglandin market, which is expected to grow significantly in the coming years. The Asia Pacific region is home to some of the world’s most populous countries, such as China and India, which present a vast market for prostaglandin-based medications. The increasing prevalence of chronic diseases such as arthritis and cancer, which require the use of prostaglandin-based medications is among the important reasons for the market growth of the prostaglandin market in the region. For instance, as per the World Health Organization (WHO), Cancer is one of the leading causes of death worldwide, killing nearly 10 million people in 2020.

Access sample report (including graphs, charts, and figures): https://univdatos.com/get-a-free-sample-form-php/?product_id=44154

Further, the Asia-Pacific Prostaglandin Market is expected to grow at a strong CAGR of 6% during the forecast period (2022-2030). The growing trend towards personalized medicine, which involves the use of prostaglandin-based medications that are tailored to the specific needs of individual patients.

APAC Prostaglandin Market Revenue (2020-2030)- USD Mn

Based on type, the market is segmented into synthetic and natural. As per our analysis, the synthetic segment acquired a major share in 2021. Synthetic prostaglandins are typically used in the treatment of a variety of conditions, including ulcers, glaucoma, and erectile dysfunction. Synthetic prostaglandin can be produced in large quantities which is an important factor for the large share of the prostaglandin segment..

Based on the category, the market is segmented into human and veterinary. As per our analysis, the human held the dominant share in 2021. The rising prevalence of chronic diseases, along with the rapidly rising population of humans globally is the major reason for the dominant share of the human prostaglandin segment in the market. Furthermore, the increasing prevalence of inflammation among human population is also an attributing factor for the domination of the segment.

Based on application, the market is segmented into cardiovascular, gynecological and obstetrical, ophthalmologic, and others. As per our analysis, the cardiovascular segment acquired a major share in 2021. The increasing prevalence of cardiac diseases is the main reason for the large share of cardiovascular diseases in the prostaglandin market. For instance, according to a study by the Indian Medical Research Council and the Registry of India, about 60% of the world’s heart diseases can be traced back to India.

For a detailed analysis of Global Prostaglandin Market browse through – https://univdatos.com/report/prostaglandin-market/

Global Prostaglandin Market Segmentation

Market Insight, by Type

• Synthetic
• Natural

Market Insight, by Category

• Human
• Veterinary

Market Insight, by Application

• Cardiovascular
• Gynecological and Obstetrical
• Ophthalmologic
• Others

Market Insight, by Region

• North America
  • U.S.
  • Canada
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • India
  • Rest of APAC
• Rest of the World

Top Company Profiles

• Sanofi
• Cayman Chemical• YONSUNG Fine Chemicals Co.• Johnson Matthey• Chirogate International Inc.• Everlight Chemical Industrial Co.• Merck KGaA• Zhejiang Ausun Pharmaceutical Co., Ltd.• AspenBio• Pfizer Inc.